Cost analysis of monitoring asthma treatment using sputum cell counts;Analyse du coût du traitement de l'asthme établi selon la numération cellulaire des expectorations

Canadian Respiratory Journal

Volumn 15, Issue 7, 2008, Pages 370-374

  D'silva, Liesel ^a   Gafni, Amiram ^b   Thabane, Lehana ^c,d,e   Jayaram, Lata ^a   Hussack, Pat ^a   Hargreave, Frederick E ^a   Nair, Parameswaran ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

^e CENTRE FOR EVALUATION OF MEDICINES   (Canada)

Author keywords

Asthma; Cost; Spirometry; Sputum cell counts; Symptoms

Indexed keywords

ANTIBIOTIC AGENT; BECLOMETASONE DIPROPIONATE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID DERIVATIVE; FLUTICASONE; PREDNISONE;

ADULT; ARTICLE; ASTHMA; CANADA; CELL COUNT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST OF ILLNESS; DISEASE SEVERITY; DRUG COST; FEMALE; GENERAL PRACTITIONER; HEALTH CARE COST; HOSPITAL COST; HUMAN; INTERMETHOD COMPARISON; MALE; MEDICAL FEE; MULTICENTER STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPIROMETRY; SPUTUM ANALYSIS; STRUCTURED QUESTIONNAIRE; SYMPTOMATOLOGY; COMPARATIVE STUDY; COST; CYTOLOGY; ECONOMICS; HOSPITALIZATION; METHODOLOGY; MIDDLE AGED; MONITORING; QUESTIONNAIRE; SPUTUM;

ADULT; ASTHMA; CELL COUNT; COSTS AND COST ANALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SPIROMETRY; SPUTUM;

EID: 59149094255     PISSN: 11982241     EISSN: None     Source Type: Journal    
DOI: 10.1155/2008/946735     Document Type: Article

References (15)

1. Green RH, Brightling CE, McKenna S, et al. Asthma exacerbations and sputum eosinophil counts: A randomised controlled trial. Lancet 2002;360:1715-21.
2. Jayaram L, Pizzichini MM, Cook RJ, et al. Determining asthma treatment by monitoring sputum cell counts: Effect on exacerbations. Eur Respir J 2006;27:483-94.
3. Schedule of Benefits for Physician Services. Ministry of Health and Long-Term Care, Ontario, 2006.
4. Hargreave FE. Quantitative sputum cell counts as a marker of airway inflammation in clinical practice. Curr Opin Allergy Clin Immunol 2007;7:102-6.
5. Seung SJ, Mittmann N. Urgent care costs of uncontrolled asthma in Canada, 2004. Can Respir J 2005;12:435-6.
6. Paltiel AD, Fuhlbrigge AL, Kitch BT, et al. Cost-effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: Results from the asthma policy model. J Allergy Clin Immunol 2001;108:39-46.
7. Barnes NC, Thwaites RM, Price MJ. The cost-effectiveness of inhaled fluticasone propionate and budesonide in the treatment of asthma in adults and children. Respir Med 1999;93:402-7.
8. Menendez R, Stanford RH, Edwards L, Kalberg C, Rickard K. Cost-efficacy analysis of fluticasone propionate versus zafirlukast in patients with persistent asthma. Pharmacoeconomics 2001;19:865-74.
9. Perera BJ. Efficacy and cost effectiveness of inhaled steroids in asthma in a developing country. Arch Dis Child 1995;72:312-5.
10. Bolton MB, Tilley BC, Kuder J, Reeves T, Schultz LR. The cost and effectiveness of an education program for adults who have asthma. J Gen Intern Med 1991;6:401-7.
11. Berggren F, Ekström T. A cost-effectiveness study comparing the as-needed use of formoterol (Oxis) and terbutaline (Bricanyl) in patients with moderate to severe asthma. Respir Med 2001;95:753-8.
12. Evans MF, Frank J. Efficacy and cost benefit of inhaled corticosteroids in patients considered to have mild asthma in primary care practice. Can Fam Physician 1997;43:632-3.
13. Kennedy WA, Girard F, Chaboillez S, et al. Cost-effectiveness of various diagnostic approaches for occupational asthma. Can Respir J 2007;14:276-80.
14. Pavord ID, Brightling CE, Woltmann G, Wardlaw AJ. Non-eosinophilic corticosteroid unresponsive asthma. Lancet 1999;353:2213-4.
15. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005;352:2163-73.